CRISPR-Engineered Blood Stem Cells Open a New Frontier for Precision Cancer Immunotherapy
Gene-edited donor hematopoietic stem and progenitor cells enable targeted AML treatment with gemtuzumab ozogamicin while shielding and preserving healthy blood formation....
